Increased expression of cofilin has been previously demonstrated in various human cancers including nonsmall cell lung cancer and squamous esophageal carcinoma, and overexpression of cofilin was frequently associated with adverse prognosis and resistance to therapy [7–10]. This evidence concerns the gene CFL1 and cancer.